Agatha, a Document Management Software for Clinical Trials and Research, Surpasses 80,000 Users
Adopted by over 1,500 medical institutions worldwide, supporting the efficiency of clinical trials
Agatha Inc. (hereinafter “the Company”) is pleased to announce that its cloud-based clinical trial document management system, “Agatha,” has surpassed 80,000 users worldwide.
Today, “Agatha” is used by more than 1,500 medical institutions and a wide range of life sciences organizations globally, including pharmaceutical and medical device companies, CROs, SMOs, and clinical laboratories, supporting the digital transformation of clinical trials and research.
Background of User and Adoption Growth
“Agatha” is a cloud service that streamlines the sharing and management of clinical trial-related documents between medical institutions and pharmaceutical companies, and has been increasingly adopted by a wide range of stakeholders, including medical institutions, pharmaceutical companies, medical device companies, CROs, SMOs, and clinical laboratories in Japan.
By centralizing the exchange and management of clinical trial documents - traditionally handled through paper and email - on the cloud, Agatha has enabled both improved operational efficiency and enhanced quality.
In recent years, as the need for digitalization and operational efficiency in clinical trials has grown, Agatha has been recognized as a platform that facilitates seamless information sharing among stakeholders, leading to expanded adoption among both medical institutions and pharmaceutical companies.
Comment from Chiemi Kamakura, CEO of Agatha Inc.
“We are delighted that Agatha has surpassed 80,000 users globally and has been adopted by more than 1,500 medical institutions. We would like to express our sincere gratitude to all medical institutions and pharmaceutical companies that continue to use our service.
Agatha has evolved together with our users as a platform that connects various stakeholders involved in clinical trials and supports the efficient management and sharing of documents. We believe that these accumulated efforts have led to the current expansion of its usage.
Moving forward, we will continue to enhance the value of our services to contribute to a society where better treatment options can be delivered to patients as quickly as possible through the efficiency of clinical trials and clinical research.”
About Agatha Inc.
Agatha Inc. was founded with the vision of contributing to improved quality, speed, and efficiency in clinical trials, clinical research, and manufacturing by providing “Agatha,” a cloud service for sharing, managing, and storing clinical trial and quality-related documents for medical institutions, pharmaceutical companies, medical device companies, CROs, SMOs, and clinical laboratories.
Our mission is to leverage cutting-edge technology to build systems and infrastructure that enable the creation of new treatments and medicines, contributing to healthier lives for people around the world. We also aim to help create an environment where future generations worldwide can access rich lifestyles, culture, technology, and healthcare.
Company Information
Company Name: Agatha Inc.
Representative: Chiemi Kamakura, Representative Director & CEO
Headquarters: Kabuto One 9F, WeWork, 7-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo 103-0026, Japan
European Office: 132 rue Bossuet, 69006 Lyon, France
Capital: 1.094 billion yen (including capital reserve)
Established: October 2, 2015
Website: https://en.agathalife.com/
For Media Inquiries:
Contact: Marion Béhier
Email: [email protected]